普祺医药 (873969.OC)

+ 收藏

现金流量表(普祺医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2022年年报2022年三季报2022年中报
上市前/上市后 上市后上市后上市后上市后上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) ---2,750,000.002,750,000.002,750,000.00
 收到的税费返还(元) --68,554.755,757,131.88--
 收到其他与经营活动有关的现金(元) 2,891,902.091,746,456.551,652,971.911,009,221.94981,490.70175,573.49
 经营活动现金流入小计(元) 2,891,902.091,746,456.551,721,526.669,516,353.823,731,490.702,925,573.49
 购买商品、接受劳务支付的现金(元) 2,132,637.672,478,145.971,981,312.351,071,201.89669,263.69316,837.19
 支付给职工以及为职工支付的现金(元) 54,206,173.3740,568,928.8924,804,224.0837,605,105.1524,595,452.3715,544,013.35
 支付的各项税费(元) 55,212.9947,224.052,305,313.3465,788.2630,528.0030,528.00
 支付其他与经营活动有关的现金(元) 68,456,499.2951,431,321.7830,928,458.6653,735,836.5038,822,213.6521,386,395.57
 经营活动现金流出小计(元) 124,850,523.3294,525,620.6960,019,308.4392,477,931.8064,117,457.7137,277,774.11
 经营活动产生的现金流量净额平衡项目(元) --1,974,189.46---
 经营活动产生的现金流量净额(元) -121,958,621.23--58,297,781.77-82,961,577.98--34,352,200.62
二、投资活动产生的现金流量
 收回投资收到的现金(元) 319,990,000.00300,000,000.00240,000,000.00300,000,000.00170,000,000.0020,000,000.00
 取得投资收益收到的现金(元) 1,798,018.081,695,191.77991,630.13876,678.45443,765.1536,054.79
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) ---1,927,904.881,925,504.881,925,504.88
 投资活动现金流入小计(元) 321,788,018.08301,695,191.77240,991,630.13302,804,583.33172,369,270.0321,961,559.67
 购建固定资产、无形资产和其他长期资产支付的现金(元) 3,333,552.062,247,107.001,899,697.001,902,448.95341,215.00180,420.00
 投资支付的现金(元) 189,990,000.00170,000,000.00160,000,000.00400,000,000.00260,000,000.0020,000,000.00
 投资活动现金流出小计(元) 193,323,552.06172,247,107.00161,899,697.00401,902,448.95260,341,215.0020,180,420.00
 投资活动产生的现金流量净额(元) 128,464,466.02129,448,084.7779,091,933.13-99,097,865.62-87,971,944.971,781,139.67
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 89,999,999.20--164,763,162.00164,763,162.0028,763,162.00
 取得借款收到的现金(元) 30,000,000.00--20,000,000.0020,000,000.007,663,276.00
 筹资活动现金流入小计(元) 119,999,999.20--184,763,162.00184,763,162.0036,426,438.00
 偿还债务支付的现金(元) 11,073,681.248,305,260.935,536,840.625,330,329.951,845,613.54-
 分配股利、利润或偿付利息支付的现金(元) 547,519.81461,409.34363,966.10537,424.66998,905.6346,307.90
 支付其他与筹资活动有关的现金(元) 2,154,021.331,506,814.002,500,870.001,979,150.001,459,710.00984,070.00
 筹资活动现金流出小计(元) 13,775,222.3810,273,484.278,401,676.727,846,904.614,304,229.171,030,377.90
 筹资活动产生的现金流量净额(元) 106,224,776.82-10,273,484.27-8,401,676.72176,916,257.39180,458,932.8335,396,060.10
五、现金及现金等价物净增加额(元) 112,730,621.6126,395,436.3612,392,474.64-5,143,186.2132,101,020.852,824,999.15
 加:期初现金及现金等价物余额(元) 16,973,533.5716,973,533.5716,973,533.5722,116,719.7822,116,719.7822,116,719.78
 期末现金及现金等价物余额(元) 129,704,155.1843,368,969.9329,366,008.2116,973,533.5754,217,740.6324,941,718.93
补充资料:
 净利润(元) -142,590,398.95--61,874,323.05-123,992,629.25--44,485,285.08
 资产减值准备(元) 18,218.53-----
 固定资产和投资性房地产折旧(元) 920,093.11-420,151.61704,187.82-337,011.81
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 920,093.11-420,151.61704,187.82-337,011.81
 无形资产摊销(元) 18,141.59-9,070.80---
 长期待摊费用摊销(元) 1,275,141.43-613,142.111,054,209.34-484,154.76
 处置固定资产、无形资产和其他长期资产的损失(元) ----2,654.87--2,654.87
 固定资产报废损失(元) ---1,522.85-1,522.85
 公允价值变动损失(元) -1,177,461.97--343,054.81-280,328.76--109,314.07
 财务费用(元) 760,694.58-1,236,429.02821,794.30-121,847.89
 投资损失(元) -395,295.84--991,630.13-861,335.98-45,260.27
 存货的减少(元) 6,370.87--456,874.81-347,911.85--347,911.85
 经营性应收项目的减少(元) -2,593,928.04--2,342,597.396,658,531.36-4,176,625.71
 经营性应付项目的增加(元) 3,833,405.04--11,180,871.5812,359,999.96--3,163,040.17
 其他(元) 15,967,917.13-13,743,776.1719,634,369.61-8,106,114.40
 现金的期末余额(元) 129,704,155.18-16,973,533.5716,973,533.57-24,941,718.93
 减:现金的期初余额(元) 16,973,533.57-22,116,719.7822,116,719.78-22,116,719.78
 现金及现金等价物的净增加额(元) 112,730,621.61--5,143,186.21-5,143,186.21-2,824,999.15
公告日期 2024-03-082023-10-272023-08-252023-04-172023-10-272023-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院